| __timestamp | PTC Therapeutics, Inc. | Travere Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 79838000 | 570979 |
| Thursday, January 1, 2015 | 121816000 | 2185000 |
| Friday, January 1, 2016 | 117633000 | 4554000 |
| Sunday, January 1, 2017 | 4577000 | 3605000 |
| Monday, January 1, 2018 | 12670000 | 5527000 |
| Tuesday, January 1, 2019 | 12135000 | 5234000 |
| Wednesday, January 1, 2020 | 18942000 | 6126000 |
| Friday, January 1, 2021 | 32328000 | 6784000 |
| Saturday, January 1, 2022 | 44678000 | 7592000 |
| Sunday, January 1, 2023 | 65486000 | 11450000 |
Unveiling the hidden dimensions of data
In the dynamic world of biotechnology, understanding cost structures is crucial for investors and stakeholders. Over the past decade, PTC Therapeutics, Inc. and Travere Therapeutics, Inc. have shown distinct trajectories in their cost of revenue. From 2014 to 2023, PTC Therapeutics experienced a significant fluctuation, peaking in 2015 with a 50% increase from the previous year, followed by a notable dip in 2017. However, by 2023, their cost of revenue had surged by approximately 70% compared to 2014. In contrast, Travere Therapeutics displayed a more consistent growth pattern, with a steady increase culminating in a 100% rise by 2023. This divergence highlights PTC's volatile cost management compared to Travere's steady approach. Such insights are invaluable for those looking to navigate the complexities of the biotech sector.
Analyzing Cost of Revenue: Novo Nordisk A/S and Travere Therapeutics, Inc.
Cost of Revenue Trends: Pfizer Inc. vs PTC Therapeutics, Inc.
Cost of Revenue Trends: United Therapeutics Corporation vs PTC Therapeutics, Inc.
Analyzing Cost of Revenue: Neurocrine Biosciences, Inc. and Travere Therapeutics, Inc.
Cost of Revenue: Key Insights for Walgreens Boots Alliance, Inc. and Travere Therapeutics, Inc.
Cost of Revenue: Key Insights for Halozyme Therapeutics, Inc. and PTC Therapeutics, Inc.
Cost Insights: Breaking Down PTC Therapeutics, Inc. and Perrigo Company plc's Expenses
PTC Therapeutics, Inc. vs HUTCHMED (China) Limited: Efficiency in Cost of Revenue Explored
PTC Therapeutics, Inc. vs Travere Therapeutics, Inc.: Annual Revenue Growth Compared
Cost of Revenue: Key Insights for PTC Therapeutics, Inc. and Dyne Therapeutics, Inc.
ACADIA Pharmaceuticals Inc. vs Travere Therapeutics, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue Comparison: Travere Therapeutics, Inc. vs BioCryst Pharmaceuticals, Inc.